MAEA overexpression also led to a significant drop in the proliferation of tumor cells that were or were not treated with oxaliplatin (Fig. 3A, B), in addition to significantly reducing the oxaliplatin IC50 value for these cell lines (Fig. 3C, D). The gene discussed is MAEA; the disease is neoplasm.